Functional experiments indicated that silencing of circHIPK3 impeded GC progression by inhibiting proliferation, migration, invasion and glutaminolysis of GC cells through miR-876-5p/PIK3R1 axis, suggesting a potential therapeutic strategy for GC in the future. The gene discussed is PIK3R1; the disease is gastric cancer.